X-141879425-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138702.1(MAGEC3):āc.509C>Gā(p.Ala170Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,159,966 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138702.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000122 AC: 13AN: 106814Hom.: 0 Cov.: 21 AF XY: 0.0000332 AC XY: 1AN XY: 30082
GnomAD3 exomes AF: 0.0000314 AC: 4AN: 127516Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 37552
GnomAD4 exome AF: 0.0000218 AC: 23AN: 1053111Hom.: 0 Cov.: 32 AF XY: 0.00000894 AC XY: 3AN XY: 335427
GnomAD4 genome AF: 0.000122 AC: 13AN: 106855Hom.: 0 Cov.: 21 AF XY: 0.0000332 AC XY: 1AN XY: 30131
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2024 | The c.509C>G (p.A170G) alteration is located in exon 3 (coding exon 3) of the MAGEC3 gene. This alteration results from a C to G substitution at nucleotide position 509, causing the alanine (A) at amino acid position 170 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at